Tag Archives: Toxic Epidermal Necrolysis

Featured Stories
Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

E-cigarettes Could Increase Risk of Lung Infections

E-cigarettes Could Increase Risk of Lung Infections

New research suggests the liquid used in electronic cigarettes could increase the risk of viral lung infections, regardless of whether it contains nicotine.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

What is Stevens-Johnson Syndrome and How is it Related to Zithromax?

What is Stevens-Johnson Syndrome & it's Link to Zithromax?

Stevens-Johnson Syndrome is a severe reaction that affects the skin and mucous membranes. It causes a rash that spreads and blisters, ultimately causing the top layer of the skin to shed and die. When SJS affects more than 30 percent … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , , , , , |

Zithromax: An Overview of Potential Side Effects

Zithromax: An Overview of Potential Side Effects

Zithromax, known generically as azithromycin, is an antibiotic manufactured by Pfizer. It is used to treat bacterial infections such as pneumonia, sexually transmitted diseases (STDs) and infections of the ears, lungs, sinuses, skin, throat and reproductive organs. Azithromycin is classified … Continue reading

Posted in Pharmaceuticals, Zithromax | Tagged , , , , , , , , , , , , , , , , , , , , , , |

Zithromax Linked to Rare but Extremely Serious Skin Side Effect

Zithromax Linked to Rare but Very Serious Skin Side Effect

Zithromax, a widely prescribed antibiotic, has been linked to a number of severe side effects, including the serious allergic skin reactions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Stevens-Johnson is “a rare, serious disorder” of the skin and mucous … Continue reading

Posted in Pharmaceuticals, Zithromax | Tagged , , , , |

Dilantin Linked to Stevens-Johnson Syndrome, a Dangerous Skin Condition

Dilantin Linked to Stevens-Johnson Syndrome

Dilantin, the anti-epileptic drug that has been in use for decades is one of many drugs associated with the related skin conditions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Though these conditions are rare, when they do occur they … Continue reading

Posted in Acetaminophen / Tylenol, Dilantin, Health Concerns, Lamictal, Pharmaceuticals, Zithromax | Tagged , , , , |

Motrin Lacks Warning on Dangerous Skin Reactions

Motrin, the pain killer known generically as ibuprofen, can cause an allergic reactions – < "http://www.yourlawyer.com/topics/overview/stevens_johnson_syndrome">Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) – that make skin shed off. According to BNET, citing a California state appeals court ruling, Johnson … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.